Cempra Pharmaceuticals

Cempra Pharmaceuticals company information, Employees & Contact Information

Cempra develops novel, well-differentiated antibiotics to meet critical unmet medical needs. Two lead products, both in clinical-stage development, address the urgent and increasing need for new treatments targeting drug-resistant bacterial infections in both the hospital and the community.

Company Details

Employees
12
Founded
-
Address
6320 Quadrangle Drive,
Phone
(919)313-6601
Email
in****@****pra.com
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
Website
cempra.com
Keywords
Comuna 1.
HQ
Chapel Hill, NORTH CAROLINA
Looking for a particular Cempra Pharmaceuticals employee's phone or email?

Cempra Pharmaceuticals Questions

News

With Melinta Merger, Cempra Lands on Its Feet Despite Regulatory Struggles - Pharmaceutical Technology

With Melinta Merger, Cempra Lands on Its Feet Despite Regulatory Struggles Pharmaceutical Technology

Cempra and Melinta Announce Merger to Form Leading, - GlobeNewswire

Cempra and Melinta Announce Merger to Form Leading, GlobeNewswire

Melinta grows pipeline through reverse merger with Cempra - BioPharma Dive

Melinta grows pipeline through reverse merger with Cempra BioPharma Dive

Another setback for Cempra’s solithromycin, this time in gonorrhea - Fierce Biotech

Another setback for Cempra’s solithromycin, this time in gonorrhea Fierce Biotech

Efficacy and safety of oral solithromycin versus oral moxifloxacin for treatment of community-acquired bacterial pneumonia: a global, double-blind, multicentre, randomised, active-controlled, non-inferiority trial (SOLITAIRE-ORAL) - The Lancet

Efficacy and safety of oral solithromycin versus oral moxifloxacin for treatment of community-acquired bacterial pneumonia: a global, double-blind, multicentre, randomised, active-controlled, non-inferiority trial (SOLITAIRE-ORAL) The Lancet

Concerns at Wockhardt, Hospira plants factor into CRL issued to Cempra - Fierce Pharma

Concerns at Wockhardt, Hospira plants factor into CRL issued to Cempra Fierce Pharma

Cempra Seals Merger Deal With This Antibiotics Biopharmaceutical - BioSpace

Cempra Seals Merger Deal With This Antibiotics Biopharmaceutical BioSpace

FDA Rejects NDAs for Cempra Bacterial Pneumonia Candidate Solithromycin - Genetic Engineering and Biotechnology News

FDA Rejects NDAs for Cempra Bacterial Pneumonia Candidate Solithromycin Genetic Engineering and Biotechnology News

Cempra, Melinta to Merge Into New Commercial Stage Anti-Infectives Firm - drugdiscoverytrends.com

Cempra, Melinta to Merge Into New Commercial Stage Anti-Infectives Firm drugdiscoverytrends.com

Cempra hopes for antibiotics blockbuster dashed - Business North Carolina

Cempra hopes for antibiotics blockbuster dashed Business North Carolina

Cempra Plans $100 Mln Public Offering - RTTNews

Cempra Plans $100 Mln Public Offering RTTNews

Cempra pulls European marketing application for antibiotic - BioPharma Dive

Cempra pulls European marketing application for antibiotic BioPharma Dive

Cempra pulls EU antibiotic filing following EMA questioning - Fierce Biotech

Cempra pulls EU antibiotic filing following EMA questioning Fierce Biotech

Wockhardt problems could delay approval of Cempra's antibiotic - Fierce Pharma

Wockhardt problems could delay approval of Cempra's antibiotic Fierce Pharma

Cempra’s Fusidic Acid Antibiotic Meets Phase III Endpoints for Treating ABSSSI - Genetic Engineering and Biotechnology News

Cempra’s Fusidic Acid Antibiotic Meets Phase III Endpoints for Treating ABSSSI Genetic Engineering and Biotechnology News

After FDA delays pneumonia antibiotic, Cempra’s shares plummet - BioPharma Dive

After FDA delays pneumonia antibiotic, Cempra’s shares plummet BioPharma Dive

Melinta merges with faltering Cempra, bagging a Nasdaq listing and a pipeline of anti-infective programs - Fierce Biotech

Melinta merges with faltering Cempra, bagging a Nasdaq listing and a pipeline of anti-infective programs Fierce Biotech

Cempra drug narrowly wins support of FDA panel - BioPharma Dive

Cempra drug narrowly wins support of FDA panel BioPharma Dive

FDA panel, by a whisker, votes yes on Cempra’s antibiotic - Fierce Biotech

FDA panel, by a whisker, votes yes on Cempra’s antibiotic Fierce Biotech

Cempra hit with FDA delay as manufacturing, safety issues blight antibiotic - Fierce Biotech

Cempra hit with FDA delay as manufacturing, safety issues blight antibiotic Fierce Biotech

New Antibiotics Promising in Pneumonia, Abdominal Infection - Medscape

New Antibiotics Promising in Pneumonia, Abdominal Infection Medscape

Chapel Hill drug developer Cempra looks to raise $200M - The Business Journals

Chapel Hill drug developer Cempra looks to raise $200M The Business Journals

Next-generation Cempra antibiotic meets endpoints - Pharmafile

Next-generation Cempra antibiotic meets endpoints Pharmafile

Aisling Capital Reduces Stake in Cempra Inc (CEMP) - Insider Monkey

Aisling Capital Reduces Stake in Cempra Inc (CEMP) Insider Monkey

Top Cempra Pharmaceuticals Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant